SAB.F Sonic Healthcare Limited

Healthcare Biotechnology Frankfurt Exchange
12.30 EUR
Close of Nov 12, 2026
10.72 13.75
Market cap
EUR 6.08B
P/E
17.0x
P/B
1.16x
ROE
7.3%
Dividend yield
5.56%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is SAB.F undervalued?

Graham number
Price12.30
Graham value13.15
Discount6.5%

SAB.F trades 6.5% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sonic Healthcare Limited fundamental analysis

No fundamental analysis for Sonic Healthcare Limited yet.

Sonic Healthcare Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sonic Healthcare Limited

Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including ma…

Full company profile